- Composition Each ml contains:
- Tilmicosin 250 mg
- Excipient q.s. 1ml
AZ.TIMICOSIN ORAL is a broad-spectrum semi-synthetic bactericidal macrolide antibiotic synthesized from tylosin. It has an antibacterial spectrum that is predominantly effective against Mycoplasma s.p., Pasteurella s.p. and Haemophilus s.p.p. and various Gram-positive organisms such as Corynebacterium spp. It is believed to affect bacterial protein synthesis through binding to 50S ribosomal subunits. Cross-resistance between tilmicosin and other macrolide antibiotics has been observed. Following oral administration, tilmicosin is excreted mainly via the bile into the faeces, with a small proportion being excreted via the urine.
AZ.TIMICOSIN is indicated for the control and treatment of respiratory infections associated with tilmicosin-susceptible micro-organisms such as Mycoplasma spp., Pasteurella multocida, Heamophilus sp., Actinomyces pyogenes and Mannheimia haemo- lytica in chickens, turkeys, duck, goose.
Administration and Dosage
Dissolve into drinking water or mix with feed for 3-5 days.
Poultry: 15-20 mg/kg bodyweight, or 1ml/12-16kg b.w., equivalent 1ml per 2-3 litres of drinking water for 3 days for the treatment and prevention of respiratory disease in chicken flocks, associated with Mycoplasma gallisepticum and M. synoviae has been demonstrated.
- Broilers: 12 days.
- Turkeys: 19 days.
- Swine: 14 days.
Bottle of 100ml and 1000 ml.
Veterinary use only